1. Home
  2. AKTX vs RAY Comparison

AKTX vs RAY Comparison

Compare AKTX & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • RAY
  • Stock Information
  • Founded
  • AKTX N/A
  • RAY 1993
  • Country
  • AKTX United States
  • RAY Hong Kong
  • Employees
  • AKTX N/A
  • RAY N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • RAY Consumer Electronics/Appliances
  • Sector
  • AKTX Health Care
  • RAY Consumer Discretionary
  • Exchange
  • AKTX Nasdaq
  • RAY Nasdaq
  • Market Cap
  • AKTX 26.5M
  • RAY 21.6M
  • IPO Year
  • AKTX N/A
  • RAY 2024
  • Fundamental
  • Price
  • AKTX $1.02
  • RAY $0.50
  • Analyst Decision
  • AKTX Strong Buy
  • RAY
  • Analyst Count
  • AKTX 2
  • RAY 0
  • Target Price
  • AKTX $3.30
  • RAY N/A
  • AVG Volume (30 Days)
  • AKTX 467.2K
  • RAY 1.5M
  • Earning Date
  • AKTX 11-18-2025
  • RAY 01-01-0001
  • Dividend Yield
  • AKTX N/A
  • RAY N/A
  • EPS Growth
  • AKTX N/A
  • RAY N/A
  • EPS
  • AKTX N/A
  • RAY 0.06
  • Revenue
  • AKTX N/A
  • RAY $10,120,519.00
  • Revenue This Year
  • AKTX N/A
  • RAY N/A
  • Revenue Next Year
  • AKTX N/A
  • RAY N/A
  • P/E Ratio
  • AKTX N/A
  • RAY $8.02
  • Revenue Growth
  • AKTX N/A
  • RAY 17.57
  • 52 Week Low
  • AKTX $0.57
  • RAY $0.40
  • 52 Week High
  • AKTX $3.70
  • RAY $3.68
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 55.06
  • RAY 32.72
  • Support Level
  • AKTX $0.90
  • RAY $0.40
  • Resistance Level
  • AKTX $1.24
  • RAY $0.55
  • Average True Range (ATR)
  • AKTX 0.14
  • RAY 0.04
  • MACD
  • AKTX 0.02
  • RAY 0.06
  • Stochastic Oscillator
  • AKTX 53.70
  • RAY 65.13

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks: